Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $13.5500 (-3.15%) ($13.5300 - $14.2900) on Wed. Jun. 28, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.52% (three month average) | RSI | 64 | Latest Price | $13.5500(-3.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.4% a day on average for past five trading days. | Weekly Trend | HALO advances 4.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.26% in a week (0% probabilities). VIXM(-13%) UUP(-10%) TLT(-6%) SHY(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.26% (StdDev 2.52%) | Hourly BBV | 0 () | Intraday Trend | -4% | | | |
|
5 Day Moving Average | $14.37(-5.71%) | 10 Day Moving Average | $14.16(-4.31%) | 20 Day Moving Average | $13.52(0.22%) | To recent high | -9% | To recent low | 14.8% | Market Cap | $1.852b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |